Dr. Sloan's clinical practice specializes in the treatment of primary brain tumors and brain metastases with radiotherapy. As a physician-scientist, she leads a translational research laboratory within the University of Minnesota Brain Tumor Program (UMBTP), focused on understanding the role of myeloid cells in primary brain tumors. Sloan is particularly interested in the impact of radiotherapy on deleterious peripheral blood myeloid cell populations in glioblastoma. The overall goal of her translational science program is to personalize radiation therapy based on systemic immune biomarkers.
Radiation oncology; Brain tumors; Brain metastases
AddressMasonic Cancer Center
420 Delaware St. SE
Minneapolis, MN 55455